2-Chloro-2'-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4

Leukemia

Volumn 14, Issue 2, 2000, Pages 299-306

  Nomura, Y ^a   Inanami, O ^a   Takahashi, K ^a   Matsuda, A ^b   Kuwabara, M ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

2 Chloro 2' deoxyadenosine; Apoptosis; Caspase; Fas; MOLT 4

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE INHIBITOR; CLADRIBINE; CYCLOHEXIMIDE; DEOXYCYTIDINE; ENZYME PRECURSOR; FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; DRUG MECHANISM; ENZYME DEGRADATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

EID: 0033951610     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401649     Document Type: Article

References (44)

1. Saven A, Lemon RH, Kosty M, Beutler E, Piro LD. 2-Chlorodeoxyadenosine(2-CdA) activity in patients with previously untreated chronic lymphocytic leukemia (CLL). Blood 1993; 82: 445a.
2. Tallman MS, Hakimian D, Variakojis D, Koslow D, Sisney GA, Rademaker AW, Rose E, Kaul K. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 1992; 80: 2203-2209.
3. Huang M, Ashmun RA, Avery TL, Kuehl M, Blakley RL. Effects of cytotoxicity of 2-chloro-2′-deoxyadenosine and 2-bromo-2′-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics. Cancer Res 1986; 46: 2362-2368.
4. Keane RW, Srinivasan A, Foster LM, Testa MP, Ord T, Nonner D, Wang HG, Reed JC, Bredesen DE, Kagalar C. Activation of cpp32 during apoptosis of neurons and astrocytes. J Neurosci Res 1997; 48: 168-180.
5. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182: 1597-1601.
6. Cheson BD, Sorensen JM, Vena DA, Montello MJ, Damasio E, Tallman M, Annino L, Connors J, Coiffier B, Lauria F. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the group C protocol mechanism of the National Cancer Institute: a report of 979 patients. J Clin Oncol 1998; 16: 3007-3015.
7. Saven A, Burian C, Koziol JA, Piro LD. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998; 92: 1918-1926.
8. Robak T, Blasinska-Morawiec M, Blonski J, Hellmann A, Halaburda K, Konopka L, Kotlarek-Haus S, Potoczek S, Hansz J, Dmoszynska A, Urasinski I, Zdziarska B, Dwilewicz-Trojarzek J, Holowiecki J, Skotnicki AB. 2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. Eur J Haematol 1999; 62: 49-56.
9. Fridrik MA, Jäger G, Kienzer HR, Hausmaninger H, Oppitz P, Krieger O, Zabernigg A, Lang A, Neubauer M, Weidinger G, Schiller L, Seewann HL, Chott A, Linkesch W. Efficacy and toxicity of 2-chlorodeoxyadenosine (cladribine) - 2 h infusion for 5 days - as first-line treatment for advanced low grade non-Hodgkin's lymphoma. Eur J Cancer 1998; 34: 1560-1564.
10. Betticher DC, Ratschiller D, Hsu Schmitz SF, von Rohr A, Hess U, Zulian G, Wernli M, Tichelli A, Tobler A, Fey MF, Cerny T. Reduced dose of subcutaneous cladribine induced identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 1998; 9: 721-726.
11. Carson DA, Wasson DB, Esparza LM, Carrera CJ, Kipps TJ, Cottam HB. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine. Proc Natl Acad Sci USA 1992; 89: 2970-2974.
12. Tanabe K, Hiraoka W, Kuwabara M, Sato F, Matsuda A, Ueda T. Induction of DNA double-strand breaks in Chinese hamster V79 cells by 2-chlorodeoxyadenosine. Chem-Biol Interactions 1989; 71: 167-175.
13. Tanabe K, Hiraoka W, Kuwabara M, Matsuda A, Ueda T, Sato F. Modification of the repair of potentially lethal damage in plateauphase Chinese hamster cells by 2-chlorodeoxyadenosine. J Radiat Res 1988, 29: 172-181.
14. Kuwabara M, Tanabe K, Hiraoka W, Tamura Y, Sato F, Matsuda A, Ueda T. 2-Chlorodeoxyadenosine inhibits the repair of DNA double-strand breaks and does not inhibit the repair of DNA single-strand breaks in X-irradiated Chinese hamster V79 cells. Chem-Biol Interactions 1991; 79: 349-358.
15. Hirota Y, Yoshioka A, Tanaka S, Watanabe K, Otani T, Minowada J, Matsuda A, Ueda T, Wataya Y. Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells. Cancer Res 1989; 49: 915-919.
16. Carson DA, Wasson DB, Kaye J, Ullman B, Martin DW Jr, Robins RK, Montgomery JA. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc Natl Acad Sci USA 1980; 77: 6865-6869.
17. Carson DA, Wasson DB, Taetle R, Yu A. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 1983; 62: 737-743.
18. Seto S, Carrera CJ, Kubota M, Wasson DB, Carson DA. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J Clin Invest 1985; 75: 377-383.
19. Kawasaki H, Carrera CJ, Piro LD, Saven A, Kipps TJ, Carson DA. Relationship of deoxycytidine kinase and cytoplasmic 5′-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Blood 1993; 81: 597-601.
20. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res 1997; 57: 3331-3334.
21. Mo YY, Beck WT. DNA damage signals induction of Fas ligand in tumor cells. Mol Pharmacol 1999; 55: 216-222.
22. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.
23. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16.
24. Bauer MA, Vogt M, Los M, Siegel J, Wesselborg S, Schulze-Osthoff K. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J Biol Chem 1998; 273: 8048-8050.
25. Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME, Debatin KM. Activation of the CD95 (APO-1/Fas) pathway in drug- and γ-irradiation-incluced apoptosis of brain tumor cells. Cell Death Differ 1998; 5: 884-893.
26. Faris M, Kokot N, Latinis K, Kasibhatla S, Green DR, Koretzky GA, Nel A. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J Immunol 1998; 160: 134-144.
27. Ferrari D, Stepczynska A, Los M, Wesselborg S, Schulze-Osthoff K. Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95-and anticancer drug-induced apoptosis. J Exp Med 1998; 188: 979-984.
28. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365.
29. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90: 405-413.
30. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-489.
31. Leoni LM, Chao Q, Cottam HB, Genini D, Rosenbach M, Carrera CJ, Budihardjo I, Wang X, Carson DA. Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c. Proc Natl Acad Sci USA 1998; 95: 9567-9571.
32. Kazimierczuk Z, Cottam HB, Revankar GR, Robins RK. Synthesis of 2′-deoxytubercidin, 2′-deoxyadenosine, and related 2′-deoxynucleosides via a novel direct stereospecific sodium salt glycosylation procedure. J Am Chem Soc 1984; 106: 6379-6382.
33. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993; 53: 1945-1951.
34. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
35. Ramakrishnan N, Catravas GN. N-(2-mercaptoethyl)-1,3,-propanediamine (WR-1065) protects thymocytes from programmed cell death. J Immunol 1992; 148: 1817-1821.
36. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptolic cells using fluorescein labeled Annexin V. J Immunol Meth 1995; 184: 39-51.
37. Cuppen E, Nagata S, Wieringa B, Hendriks W. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis. J Biol Chem 1997; 272: 30215-30220.
38. Reutelingsperger CPM, van Heerde WL. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 1997; 53: 527-531.
39. Hampton MB, Vanags DM, Pörn-Ares MI, Orrenius S. Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis. FEBS Lett 1996; 399: 277-282.
40. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 1997; 90: 935-943.
41. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell 1998; 1: 543-551.
42. Inanami O, Takahashi K, Kuwabara M. Attenuation of caspase-3-dependent apoptosis by Trolox post-treatment of X-irradiated MOLT-4 cells. Int J Radiat Biol 1999; 75: 155-163.
43. Takahashi K, Inanami O, Kuwabara M. Effects of intracellular calcium chelator BAPTA-AM on radiation-induced apoptosis regulated by activation of SAPK/JNK and caspase-3 in MOLT-4 cells. Int J Radiat Biol 1999; 95: 1099-1105.
44. Inanami O, Takahashi K, Yoshito A, Kuwabara M. Hydrogen peroxide-induced activation of SAPK/JNK regulated by phosphatidylinositol 3-kinase in Chinese hamster V79 cells. Antiox Redox Signal 1999; 1: 113-121.